Dr. Reddy's Launches Generic Revatio

Share this article:

Dr. Reddy's Laboratories announced the launch of Sildenafil Tablets, the generic version of Pfizer's Revatio, following the FDA approval of its Abbreviated New Drug Application (ANDA).

Revatio is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening. Revatio is a phosphodiesterase type 5 inhibitor that increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation.

Sildenafil is available in 20mg dosage strength tablets in 90-count bottles.

For more information call (908) 203-4933 or visit www.drreddys.com.

Share this article:

Related Resources

close

Next Article in Generics News